Yanqin Xue – Trademark Portfolio

Entity Type: 01

Yanqin Xue holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BELYNCE and LUXEBYTE. The owner is based in Dalian, Liaoning.

No. 24, Heping Street

Xigang District

Dalian, Liaoning 116000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BELYNCE
BELYNCE
Registered 2025
LUXEBYTE
LUXEBYTE
Registered 2025

Trademark Classifications

Yanqin Xue's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Yanqin Xue have?

Yanqin Xue has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Yanqin Xue file in?

Yanqin Xue files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Yanqin Xue's most well-known trademarks?

Yanqin Xue's registered trademark portfolio includes well-known marks such as BELYNCE and LUXEBYTE. These are among 2 currently registered trademarks in the portfolio.

What is Yanqin Xue's trademark registration success rate?

Yanqin Xue has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.